- The trend backdrop is active with a 23-week active streak.
- Activity pressure is constructive, supporting the smart-money activity read.
SPERM
STO
Week ended 07 Aug 2026
Weekly Investor Report
Spermosens AB (publ) · Healthcare · Diagnostics & Research
Latest close
0.01 SEK
-13.7%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is -4.8% below the Trend Line and sits at 59.0% of its 52-week range. The latest completed week returned -13.7%, after a -15.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
34
out of 100
Latest Close
0.01 SEK
7 Aug 2026
1W Return
-13.7%
latest completed week
4W Return
-15.4%
short-term follow-through
12W Return
-10.2%
quarterly tape
Trend Breadth
44.2%
23 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 41.73% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-13.7%
Latest completed week; four-week move -15.4%.
Indicator stack
69/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.73%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is -4.8% below the Trend Line and sits at 59.0% of its 52-week range. The latest completed week returned -13.7%, after a -15.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7412-week average 0.80
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.74Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -15.4% over four weeks, -10.2% over 12 weeks, and 25.7% over one year. The current trend has remained active for 23 consecutive weeks.
Performance by holding period
Active trend streak23 weeks
Active weeks in one year23
Trend breadth44.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.59Latest activity-pressure read.
Pressure change-4361.5%Four-week change in activity pressure.
Leadership-3.09Latest relative-leadership reading.
RS change-114.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-26.7%Distance below the 52-week high.
13-week volatility8.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2614 weeks finished lower.
Best week+38.2%Week of 13 Feb.
Worst week-13.7%Week of 7 Aug.
Latest week-13.7%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains2
Flat weeks3
Modest losses5
Sharp losses9
Recent vol8.4%13-week weekly-return volatility.
Base vol9.4%52-week weekly-return volatility.
Up/down split19/27Count of positive and negative weeks in the 52-week window.
Average skew10.2% / -5.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank- / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Diagnostics & Research
4-week rank5 / 6
Group average-4.1%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD16.7%positive activity pressure
RS16.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape39/100
Trend, activity pressure, participation, and risk combine to a 39/100 tape read.
Indicator analysis71/100Latest 12-week confirmation: trend 12/12, activity pressure 4/12, relative leadership 11/12.
Activity pressure 0.74; No reversal markers Next-Week ExpectancyNegative 41.73%Next-week expectancy is negative with a 41.73% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.01 SEK | -13.7% | 0.01 SEK | 0.13 SEK | -0.59 | -3.09 | 24.8M | On |
| 31 Jul 2026 | 0.01 SEK | 0.0% | 0.01 SEK | 0.14 SEK | -0.35 | 14.56 | 8.7M | On |
| 24 Jul 2026 | 0.01 SEK | -1.9% | 0.01 SEK | 0.14 SEK | -0.18 | 16.70 | 15.9M | On |
| 17 Jul 2026 | 0.01 SEK | 0.0% | 0.01 SEK | 0.15 SEK | -0.06 | 21.47 | 7.9M | On |
| 10 Jul 2026 | 0.01 SEK | -1.9% | 0.01 SEK | 0.15 SEK | 0.01 | 20.97 | 26.6M | On |
| 3 Jul 2026 | 0.01 SEK | -7.0% | 0.01 SEK | 0.16 SEK | -0.01 | 21.32 | 7.3M | On |
| 26 Jun 2026 | 0.01 SEK | 9.6% | 0.01 SEK | 0.16 SEK | -0.14 | 34.57 | 1.2M | On |
| 19 Jun 2026 | 0.01 SEK | -1.9% | 0.01 SEK | 0.17 SEK | -0.15 | 22.24 | 20.7M | On |
| 12 Jun 2026 | 0.01 SEK | 20.5% | 0.01 SEK | 0.17 SEK | -0.17 | 27.20 | 6.6M | On |
| 5 Jun 2026 | 0.01 SEK | -6.4% | 0.01 SEK | 0.18 SEK | 0.05 | 5.68 | 9.6M | On |
| 29 May 2026 | 0.01 SEK | 4.4% | 0.01 SEK | 0.18 SEK | 0.56 | 12.14 | 35.5M | On |
| 22 May 2026 | 0.01 SEK | -8.2% | 0.01 SEK | 0.19 SEK | 0.96 | 7.00 | 31.8M | On |
| 15 May 2026 | 0.01 SEK | -5.8% | 0.01 SEK | 0.19 SEK | 1.35 | 20.40 | 30.0M | On |
| 8 May 2026 | 0.01 SEK | -7.1% | 0.01 SEK | 0.20 SEK | 1.42 | 26.23 | 57.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.